Table 2.

Results for the validation of the two genome-wide significant variants in an independent dataset of breast cancer patients with metastatic primary breast cancer at diagnosis.

SNP	Chr	Position	Ref	Alt	EAF	r2	HR	LCL	UCL	P value
rs138569520	1	226193175	T	C	0.02	0.69	1.49	0.60	3.71	0.34
rs146023652	1	226158826	C	T	0.02	0.79	1.25	0.46	3.37	0.66

ALT alternate, REF reference, EAF effect allele frequency, HR hazard rate, LCL lower control limit, UCL upper control limit, r² imputation quality.